See more : WithSecure Oyj (FSC1V.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Nicox S.A. (COX.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nicox S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Magnetic Resources NL (MAU.AX) Income Statement Analysis – Financial Results
- Navarre Minerals Limited (NML.AX) Income Statement Analysis – Financial Results
- Ceeta Industries Ltd. (CEETAIN.BO) Income Statement Analysis – Financial Results
- NR21 Société Anonyme (NR21.PA) Income Statement Analysis – Financial Results
- Arbor Rapha Capital Bioholdings Corp. I (ARCK) Income Statement Analysis – Financial Results
Nicox S.A. (COX.PA)
About Nicox S.A.
Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was founded in 1996 and is headquartered in Valbonne, France.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.24M | 8.58M | 14.42M | 8.26M | 4.72M | 15.08M | 16.00K | 9.96M | 5.98M | 747.00K | 7.61M | 0.00 | 7.42M | 1.12M | 3.36M | 20.62M | 9.63M | 6.53M | 1.18M | 1.40M | 5.47M | 0.00 |
| Cost of Revenue | 1.97M | 1.35M | 1.52M | 1.41M | 690.00K | 12.78M | 0.00 | 5.31M | 3.94M | 563.00K | 13.00K | 0.00 | 0.00 | 75.00K | 750.00K | 2.15M | 1.61M | 1.78M | 2.23M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.27M | 7.23M | 12.91M | 6.86M | 4.03M | 2.31M | 16.00K | 4.66M | 2.04M | 184.00K | 7.60M | 0.00 | 7.42M | 1.04M | 2.61M | 18.47M | 8.03M | 4.75M | -1.05M | 1.40M | 5.47M | 0.00 |
| Gross Profit Ratio | 62.40% | 84.27% | 89.49% | 82.99% | 85.37% | 15.29% | 100.00% | 46.74% | 34.17% | 24.63% | 99.83% | 0.00% | 100.00% | 93.30% | 77.69% | 89.57% | 83.33% | 72.81% | -89.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 17.99M | 17.91M | 12.73M | 17.75M | 16.33M | 9.75M | 12.17M | 6.30M | 4.41M | 3.69M | 6.47M | 9.00M | 35.16M | 51.67M | 74.28M | 44.35M | 26.97M | 16.20M | 9.25M | 16.63M | 19.69M | 12.27M |
| General & Administrative | 6.76M | 6.34M | 6.03M | 6.59M | 9.51M | 9.87M | 8.62M | 11.72M | 10.72M | 7.62M | 7.62M | 4.11M | 5.36M | 6.42M | 11.36M | 11.32M | 7.72M | 4.89M | 4.29M | 4.37M | 4.54M | 3.41M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.63M | 13.55M | 10.40M | 2.63M | 1.82M | 7.39M | 8.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.76M | 6.34M | 6.03M | 6.59M | 9.51M | 9.87M | 8.62M | 25.35M | 24.27M | 18.01M | 10.25M | 5.93M | 12.75M | 15.00M | 11.36M | 11.32M | 7.72M | 4.89M | 4.29M | 4.37M | 4.54M | 3.41M |
| Other Expenses | 213.00K | 1.15M | 1.17M | 840.00K | -840.00K | -1.02M | 13.06M | -2.68M | -789.00K | -622.00K | -377.00K | 0.00 | 0.00 | 3.64M | 3.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 24.97M | 25.40M | 19.92M | 25.18M | 25.00M | 19.36M | 20.84M | 30.93M | 23.51M | 21.20M | 16.20M | 17.63M | 51.42M | 66.67M | 81.83M | 55.67M | 34.68M | 21.09M | 13.54M | 20.99M | 24.22M | 15.67M |
| Cost & Expenses | 26.94M | 26.75M | 21.44M | 26.58M | 25.69M | 32.13M | 20.84M | 36.24M | 27.44M | 21.76M | 16.21M | 17.63M | 51.42M | 66.75M | 82.58M | 57.82M | 36.29M | 22.86M | 15.77M | 20.99M | 24.22M | 15.67M |
| Interest Income | 520.00K | 0.00 | 891.00K | 171.00K | 0.00 | 0.00 | 0.00 | 0.00 | 1.09M | 283.00K | 401.00K | 1.06M | 475.00K | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.76M | 2.02M | 2.21M | -865.00K | 0.00 | 3.00K | 0.00 | 6.00K | 857.00K | 893.00K | 1.62M | 6.00K | 95.00K | 159.00K | 0.00 | 0.00 | 2.00K | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 16.71M | 29.42M | -7.11M | 1.80M | 2.94M | 171.00K | 423.00K | 1.34M | 1.64M | 588.00K | 513.00K | 1.58M | 1.37M | 6.93M | 885.00K | 529.00K | 593.00K | 499.00K | 414.00K | 548.00K | 415.00K | 134.00K |
| EBITDA | -4.99M | 11.80M | -14.12M | -16.52M | -18.03M | -18.94M | -6.27M | -26.58M | -19.06M | -20.71M | -8.05M | -15.00M | -42.15M | -53.42M | -78.33M | -36.67M | -24.99M | -16.51M | -14.01M | -19.04M | -18.34M | -15.54M |
| EBITDA Ratio | -95.14% | 137.47% | -97.91% | -200.00% | -382.15% | -125.58% | -39,168.75% | -266.75% | -318.54% | -2,771.75% | -105.73% | 0.00% | -567.82% | -4,773.99% | -2,329.80% | -177.83% | -259.52% | -252.96% | -1,185.45% | -1,356.20% | -335.41% | 0.00% |
| Operating Income | -21.70M | -17.62M | -7.01M | -18.32M | -20.97M | -18.52M | -7.78M | -28.90M | -21.78M | -17.58M | -8.75M | -17.63M | -44.00M | -61.99M | -79.21M | -37.20M | -26.66M | -16.34M | -14.59M | -19.59M | -18.76M | -15.67M |
| Operating Income Ratio | -413.89% | -205.31% | -48.62% | -221.84% | -444.56% | -122.80% | -48,650.00% | -290.07% | -364.08% | -2,352.88% | -114.88% | 0.00% | -592.71% | -5,539.32% | -2,356.13% | -180.40% | -276.82% | -250.25% | -1,234.09% | -1,395.23% | -343.00% | 0.00% |
| Total Other Income/Expenses | -8.59M | -29.78M | -11.31M | -4.45M | 2.69M | -594.00K | 1.09M | 995.00K | 229.00K | -610.00K | -1.44M | 1.05M | 380.00K | 1.48M | 5.46M | 5.18M | 2.22M | 1.06M | 1.01M | 337.00K | 2.47M | 2.38M |
| Income Before Tax | -30.29M | -47.41M | -18.07M | -22.78M | -18.28M | -19.11M | -6.69M | -27.91M | -21.55M | -18.19M | -10.18M | -16.58M | -43.62M | -60.51M | -73.76M | -32.02M | -24.44M | -15.28M | -13.58M | -19.25M | -16.29M | -13.29M |
| Income Before Tax Ratio | -577.78% | -552.31% | -125.29% | -275.76% | -387.49% | -126.74% | -41,812.50% | -280.09% | -360.25% | -2,434.54% | -133.75% | 0.00% | -587.59% | -5,407.24% | -2,193.78% | -155.26% | -253.74% | -234.07% | -1,148.56% | -1,371.23% | -297.88% | 0.00% |
| Income Tax Expense | -2.53M | -3.64M | 28.00K | -3.86M | 113.00K | -10.82M | 52.00K | 34.00K | 170.00K | -41.00K | 63.00K | 54.00K | 334.00K | -157.00K | 132.00K | 129.00K | 261.00K | 228.00K | 207.00K | 227.00K | -596.00K | -1.77M |
| Net Income | -27.76M | -43.76M | -18.10M | -18.92M | -18.39M | -3.62M | -19.04M | -27.94M | -16.00M | -17.79M | -10.19M | -16.64M | -43.95M | -60.35M | -73.89M | -32.14M | -24.70M | -15.51M | -13.78M | -19.48M | -15.69M | -11.53M |
| Net Income Ratio | -529.55% | -509.86% | -125.48% | -229.08% | -389.89% | -23.99% | -118,968.75% | -280.43% | -267.39% | -2,381.93% | -133.82% | 0.00% | -592.09% | -5,393.21% | -2,197.71% | -155.89% | -256.45% | -237.56% | -1,166.07% | -1,387.39% | -286.98% | 0.00% |
| EPS | 0.00 | -1.17 | -0.54 | -0.62 | -0.62 | -0.13 | -0.80 | -1.25 | -0.99 | -1.22 | -0.70 | -1.14 | -3.03 | -6.01 | -6.73 | -2.98 | -2.97 | -2.08 | -1.85 | -3.70 | -3.00 | -2.39 |
| EPS Diluted | 0.00 | -1.17 | -0.54 | -0.62 | -0.62 | -0.13 | -0.80 | -1.25 | -0.99 | -1.22 | -0.70 | -1.14 | -3.03 | -6.01 | -6.73 | -2.98 | -2.97 | -2.08 | -1.85 | -3.70 | -3.00 | -2.39 |
| Weighted Avg Shares Out | 0.00 | 37.49M | 33.72M | 30.30M | 29.60M | 26.95M | 23.94M | 22.36M | 16.22M | 14.62M | 14.58M | 14.55M | 14.50M | 10.04M | 10.98M | 10.78M | 8.33M | 7.45M | 7.45M | 5.26M | 5.24M | 4.81M |
| Weighted Avg Shares Out (Dil) | 0.00 | 37.49M | 33.72M | 30.30M | 29.60M | 26.95M | 23.94M | 22.36M | 16.22M | 14.62M | 14.58M | 14.55M | 14.50M | 10.04M | 10.98M | 10.78M | 8.33M | 7.45M | 7.45M | 5.26M | 5.24M | 4.81M |
Source: https://incomestatements.info
Category: Stock Reports